AbCellera Acquires TetraGenetics, Enhancing Capabilities to Generate Antibodies Against High-Value Targets

Go back to AbCellera Acquires TetraGenetics, Enhancing Capabilities to Generate Antibodies Against High-Value Targets
(NASDAQ: ABCL) Delayed: 11.32 --0 (-0%)
Previous Close $11.32    52 Week High
Open $11.32    52 Week Low
Day High $11.32    P/E N/A 
Day Low $11.32    EPS
Volume 31,420